Mustafa Gür
Impact in
- Clinical Biochemistry top 2%
- Paraoxonase enzyme and polymorphisms
-
- Acute Myocardial Infarction Research
- Cardiovascular Disease and Adiposity
- Cardiovascular Function and Risk Factors
- Cardiovascular Health and Disease Prevention
Papers in
-
- Cardiovascular Function and Risk Factors 24
- Cardiovascular Health and Disease Prevention 22
- Cardiovascular Disease and Adiposity 19
- Acute Myocardial Infarction Research 13
- Blood Pressure and Hypertension Studies 12
-
- Paraoxonase enzyme and polymorphisms 12
- Co-authors
- Recep DemirbağRemzi YılmazMurat ÇaylıZafer ElbasanÖzcan ErelTaner ŞekerŞahabettin SelekCaner Türkoğlu
- Journals
- Coronary Artery Disease (6 papers)Journal of the American College of Cardiology (6 papers)Clinical Biochemistry (4 papers)Clinical and Experimental Hypertension (4 papers)Atherosclerosis (3 papers)
- Partner nations
- TürkiyeUnited KingdomPoland
In The Last Decade
Mustafa Gür
87 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Clinical Biochemistry 194
- Cardiology and Cardiovascular Medicine 593
- Internal Medicine 90
- Nephrology 162
- Oncology 284
Countries citing papers authored by Mustafa Gür
This map shows the geographic impact of Mustafa Gür's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Gür with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Gür more than expected).
Fields of papers citing papers by Mustafa Gür
This network shows the impact of papers produced by Mustafa Gür. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Gür. The network helps show where Mustafa Gür may publish in the future.
Co-authors
The 25 scholars most cited alongside Mustafa Gür, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2014 | 6 | |
| 3 | 2014 | 15 | |
| 4 | 2014 | 8 | |
| 5 | 2014 | 1 | |
| 6 | 2014 | 1 | |
| 7 | 2013 | 13 | |
| 8 | 2013 | 27 | |
| 9 | 2013 | 5 | |
| 10 | 2013 | 5 | |
| 11 | 2013 | 20 | |
| 12 | 2013 | 27 | |
| 13 | 2013 | 4 | |
| 14 | 2012 | 7 | |
| 15 | 2012 | 17 | |
| 16 | 2008 | 53 | |
| 17 | The effect of coronary angioplasty on oxidative and antioxidative status | 2007 | 4 |
| 18 | 2007 | 45 | |
| 19 | 2006 | 52 | |
| 20 | 2006 | 5 |
About Mustafa Gür
Mustafa Gür is a scholar working on Cardiology and Cardiovascular Medicine, Clinical Biochemistry, Internal Medicine, Nephrology and Radiology, Nuclear Medicine and Imaging, having authored 88 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (24 papers), Cardiovascular Health and Disease Prevention (22 papers), Cardiovascular Disease and Adiposity (19 papers), Acute Myocardial Infarction Research (13 papers), Cardiac Imaging and Diagnostics (12 papers), Blood Pressure and Hypertension Studies (12 papers), Paraoxonase enzyme and polymorphisms (12 papers) and Inflammatory Biomarkers in Disease Prognosis (11 papers). The work is most often cited by research in Clinical Biochemistry (194 citations), Cardiology and Cardiovascular Medicine (593 citations), Internal Medicine (90 citations), Nephrology (162 citations) and Oncology (284 citations). Mustafa Gür has collaborated with scholars based in Türkiye, United Kingdom and Poland. Frequent co-authors include Recep Demirbağ, Remzi Yılmaz, Murat Çaylı, Zafer Elbasan, Özcan Erel, Taner Şeker, Şahabettin Selek, Caner Türkoğlu, Durmuş Yıldıray Şahin and Mehmet Aslan. Their work appears in journals such as Coronary Artery Disease, Journal of the American College of Cardiology, Clinical Biochemistry, Clinical and Experimental Hypertension and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.